A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer

MLA

Kai Sun, et al. “A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 28, no. 20, Feb. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....aa25b122aebf3f8758f02d2287b69d9e&authtype=sso&custid=ns315887.

APA

Kai Sun, Yitian Xu, Licheng Zhang, Polly Niravath, Jorge Darcourt, Tejal Patel, Bin S. Teh, Andrew M. Farach, Carlo Guerrero, Sunil Mathur, Mark A. Sultenfuss, Nakul Gupta, Mary R. Schwartz, Susan L. Haley, Sindhu Nair, Xiaoxian Li, Thi Truc Anh Nguyen, Joseph D. Butner, Joe Ensor, … Jenny C. Chang. (2022). A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 28(20).

Chicago

Kai Sun, Yitian Xu, Licheng Zhang, Polly Niravath, Jorge Darcourt, Tejal Patel, Bin S. Teh, et al. 2022. “A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 28 (20). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....aa25b122aebf3f8758f02d2287b69d9e&authtype=sso&custid=ns315887.